Benitec Biopharma Inc. Public Float
Benitec Biopharma Inc. (BNTC) had Public Float of $143.06 million as of 2025-12-31, per its 10-K filed 2026-09-14.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-09-14
- 2025-12-31: Entity Public Float $143.06M.
- 2024-12-31: Entity Public Float $152.96M.
- 2023-12-31: Entity Public Float $8.37M.
- 2022-12-31: Entity Public Float $4.76M.
| Period end | Entity Public Float |
|---|---|
| 2025-12-31 | $143.06M 10-K · filed 2026-09-14 |
| 2024-12-31 | $152.96M 10-K/A · filed 2026-03-20 |
| 2023-12-31 | $8.37M 10-K · filed 2024-09-26 |
| 2022-12-31 | $4.76M 10-K · filed 2023-09-21 |
| 2021-12-31 | $21.38M 10-K · filed 2022-09-02 |
| 2020-12-31 | $13.62M 10-K · filed 2021-09-20 |
| 2019-12-31 | $5.88M 10-K · filed 2020-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |